The Role of Therapeutic Anticoagulation in COVID-19
Coagulopathy has proven to be a common complication of the novel coronavirus SARS-CoV-2, with evidence of elevated D-dimers and fibrin degradation products associated with an increased incidence of thromboembolism. Despite emerging evidence describing the coagulopathy and its clinical relevance in C...
Saved in:
Main Authors: | Ruth McGovern, Patrick Conway, Isabell Pekrul, Omar Tujjar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Critical Care |
Online Access: | http://dx.doi.org/10.1155/2020/8835627 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Central Retinal Vein Occlusion with Therapeutic Level of Anticoagulation
by: Sarwat Salim, et al.
Published: (2009-01-01) -
A review of COVID-19-related thrombosis and anticoagulation strategies specific to the Asian population
by: Kai Chin Poh, et al.
Published: (2022-07-01) -
Hemorrhage of the Ramus Lumbalis of the Iliolumbar Artery as a Cause for Shock in Blunt Trauma Victims on Therapeutic Anticoagulation
by: Thomas Patrick Sullivan, et al.
Published: (2021-01-01) -
Therapeutic Approaches in COVID-19 Patients: The Role of the Renin-Angiotensin System
by: Farzaneh Ketabchi, et al.
Published: (2022-01-01) -
Influence of novel oral anticoagulants on anticoagulation care management
by: Janzic Andrej, et al.
Published: (2017-09-01)